EyePoint Pharmaceuticals Inc.



Market open

 --Real time quotes

Sep 29, 2022, 2:38 p.m.





-0.30 -3.92%


Volume 31,539

Real time quotes


Previous close

$ 7.65

$ 7.35


-0.30 -3.92%

Day low

Day high




52 week low

52 week high




George O. Elston

George O. Elston founded Chatham Street Partners. Currently, Mr. Elston is CFO & Head-Corporate Development at EyePoint Pharmaceuticals, Inc. He is also on the board of db-X ETF Trust.

Mr. Elston previously held the position of Chief Operating & Financial Officer of Optherion, Inc., Managing Partner at Chatham Street Partners, President & Chief Executive Officer at Oncology Venture US, Inc., President & Chief Executive Officer for Enzyvant, Inc., Chief Financial Officer, Secretary & Treasurer of Catalent JNP, Inc., Vice President-Finance & Government Affairs at Elusys Therapeutics, Inc., Chief Financial Officer & Senior Vice President of KBI Biopharma, Inc., Chief Financial Officer of Trillium USA, Inc., Principal at C. R. Bard, Inc. (New Jersey) and Principal at Pricewaterhousecoopers LLC.

He received an undergraduate degree from Pace University.


Date Shares Transaction Value
09/04/2020 10,000   Acquisition at $0.48 per share. 4,800
08/24/2020 10,000   Acquisition at $0.61 per share. 6,100
03/12/2020 10,000   Acquisition at $0.96 per share. 9,600
11/15/2019 10,000   Acquisition at $1.43 per share. 14,300

Officers and Executives

Dr. Jay S. Duker
Chief Operating Officer
Mr. George O. Elston
CFO & Head-Corporate Development
Dr. Said Saim
Chief Technology Officer
Dr. Dario A. Paggiarino
Chief Medical Officer & Senior Vice President
Ms. Jennifer Leonard
Chief People Officer & Senior Vice President-IT
Mr. Scott Jones
Chief Commercial Officer & Senior Vice President
Mr. Michael C. Pine
Chief Corporate Development & Strategy Officer
Mr. Ye Liu
Dr. Anthony P. Adamis
Ms. Karen L. Zaderej
Mr. Ron I. Honig
Secretary, Chief Legal Officer & Senior VP
Ms. Isabelle Lefebvre
Chief Regulatory Officer
Dr. Göran Albert Torstensson Ando
Non-Executive Chairman
Ms. Wendy F. DiCicco
Independent Director
Dr. John Barry Landis
Independent Director
Dr. David R. Guyer
Independent Director
Link to MarketWatch's Slice.